BI-RADS-NET-V2: A Composite Multi-Task Neural Network for Computer-Aided Diagnosis of Breast Cancer in Ultrasound Images With Semantic and Quantitative Explanations.
Source check: Source checked. Not independent scientific confirmation.
Finding: BI-RADS-Net-V2 used a learned ultrasound classifier with BI-RADS semantic and quantitative explanations on 1,192 breast-ultrasound images. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: The learned operation used for the specific diagnostic or biomedical result was checked in the full-text Methods.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The learned operation used for the specific diagnostic or biomedical result was checked in the full-text Methods.
- Test and result
- The reported cohort, comparison, and case-specific outcome were checked in the primary Results.
- Limitation / still unknown
- The primary text compares diagnostic and explanation performance on the stated image set; it does not establish prospective clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10443928/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.